Livento Group, Inc. 8-K

What Happened
Livento Group, Inc. (formerly NuGene International, Inc.) filed an 8-K reporting that on September 11, 2025 it entered a financing agreement (convertible promissory note) with AES Capital Management, LLC for $30,000. The note carries interest at 8% per annum and matures on September 11, 2026. The filing is signed by David Stybr, President.

Key Details

• Principal amount: $30,000.
• Interest rate: 8% per annum.
• Maturity date: September 11, 2026 (one year after issuance).
• Conversion: Any unpaid amounts may be converted into common shares (par value $0.0001) at a price equal to 65% of the average of the lowest trading price on three discrete days.

Why It Matters
This agreement provides Livento Group with short-term financing of $30,000 and creates a convertible debt obligation until repayment or conversion. Because the note can convert into common shares at a discounted conversion price, conversion would result in issuance of new shares and dilute existing shareholders. Investors should note the interest, the one-year maturity, and the specific conversion formula when assessing the company’s near-term financing and potential share dilution.